Mycophenolate is a medication that decreases your immune system’s response to a transplanted organ to prevent rejection. This medication comes in a tablet form that you can take by mouth with a glass of water as directed. The brand name of mycophenolate is CellCept®.

Oct 31, 2023 · Mycophenolate (CellCept) belongs to a drug class called antiproliferatives and works as an immunosuppressant, meaning that it weakens your immune system. This medication is used in adults and children ages 3 months and older to help prevent their body from rejecting a transplanted organ.

Mycophenolate belongs to a group of medicines known as immunosuppressive agents. It is used with other medicines (eg, cyclosporine, steroid medicine) to lower the body's natural immunity in patients who receive organ transplants (eg, kidney, heart, or liver).

Mycophenolate is used in combination with other medications to keep your body from attacking and rejecting your transplanted organ (such as kidney, liver, heart). It belongs to a class of...

Mycophenolic acid is an immunosuppressant medication used to prevent rejection following organ transplantation and to treat autoimmune conditions such as Crohn's disease and lupus. [13][14] Specifically it is used following kidney, heart, and liver transplantation. [14] . It can be given by mouth or by injection into a vein. [14] .

Mycophenolate is a disease-modifying anti-rheumatic drug (DMARD) used for lupus and vasculitis. Learn how it works, how long it takes, risks and side-effects.

Mycophenolate is used to prevent transplant organ rejection (attack of the new organ by the immune system) in people who have received kidney, heart, or liver transplants. Mycophenolate is in a class of medications called immunosuppressive agents. It works by weakening the body's immune system so it will not attack and reject the transplanted ...

Oct 21, 2024 · Mycophenolate mofetil is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants. (1)

Mycophenolate is an immunosuppressant medication used to prevent rejection of transplant organs, in particular, heart, kidney, and liver. Mycophenolate is administered as intravenous (IV) infusion or oral tablets/capsules, typically in combination with cyclosporine and corticosteroids.

Nov 4, 2024 · Mycophenolate mofetil is used to prevent organ rejection in people at least 3 months old who have received a liver, kidney, or heart transplant. Mycophenolate mofetil is also used with other medicines to prevent organ transplant rejection. Mycophenolate mofetil may also be used for purposes not listed in this medication guide.